![Medicinal Cannabis Draws Eyes as Oil Slides and Bond Yields Climb [FTSE AIM UK 50 INDEX]](https://cedclinic.com/wp-content/uploads/2026/06/ced-unsplash-ke6jYtwXDKA-1-150x150.jpg "Medicinal Cannabis Draws Eyes as Oil Slides and Bond Yields Climb [FTSE AIM UK 50 INDEX] 25")
CED Cannabis Science Digest: 3 Sleep, Oncology, and Pain Cannabis Signals Worth Watching
Three verified cannabis science signals on sleep and mental-health burden, oncology communication, and preclinical bladder-pain research, gathered in one evidence-aware digest.
CED Cannabis Science Digest: 3 Clinical-Caution Cannabis Signals Worth Watching
Three verified cannabis-related caution signals on a negative CB1 trial, FAAH translational limits, and weak PTSD efficacy evidence.
CED Cannabis Science Digest: 3 Early Therapeutic Cannabinoid Signals Worth Watching
Three verified early therapeutic cannabinoid signals on Alzheimer's disease, pain-pathway drug design, and CBD in sickle cell disease, gathered in one evidence-aware digest.
CED Cannabis Science Digest: 3 Public-Health Cannabis Signals Worth Watching
Three verified public-health cannabis signals on pregnancy outcomes, psychosis follow-up, and e-scooter road safety, gathered in one evidence-aware digest.
CED Cannabis Science Digest: 3 CBD and Cannabis Safety Signals Worth Watching
No fresh human clinical-trial-level cannabis paper stood out strongly enough for standalone coverage on June 20, 2026, but three verified lower-certainty CBD and cannabis safety signals on blood pressure, alcohol co-use, and vaping-related lung risk were…
CED Cannabis Science Digest: 3 Cannabis Use, Cognition, and Policy Signals Worth Watching
No fresh human clinical-trial-level cannabis paper stood out strongly enough for standalone coverage on June 19, 2026, but three verified lower-certainty signals on young-adult use patterns, cognition after marijuana cessation, and Bangkok regulatory…
Stigma toward individuals with cannabis use disorder across age groups: associations with familiarity and sociodemographic characteristics.
Clinical Takeaway People who personally know someone who uses cannabis tend to hold less stigmatizing attitudes toward those with cannabis use disorder, regardless of whether the person affected is an adolescent or an adult. Sociodemographic factors such…
Relationships between cannabis use and mental disorders: assessing the coherence of evidence from studies with different methodologies.
Clinical Takeaway Research consistently shows that daily cannabis use, especially when started in adolescence or young adulthood, is associated with higher rates of psychosis, bipolar disorder, anxiety, depression, and suicidal behavior. This…
International cannabis policies and their association with cannabis use, cannabis use disorder, and other psychiatric disorders.
Clinical Takeaway Legalizing cannabis for non-medical use in places like Canada and the United States has been linked to more adults using cannabis, higher rates of cannabis use disorder, and increased product potency. The research does not show a…
Clinical and Sociodemographic Correlates of Poor Medication Adherence in People With Bipolar Disorder: A Systematic Review and Meta-Analysis.
Clinical Takeaway Poor medication adherence in bipolar disorder is consistently linked to factors including substance use, younger age, and lower insight into illness. Clinicians should routinely screen for these correlates when evaluating treatment…